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Methods	A	 literature	 review	 was	 conducted	 to	determine	 the	 reagents	 previously	 used	 to	dissociate	 native	 islets.	 Using	 the	 search	 engine	PubMed,	 we	 searched	 the	 MEDLINE	 database	(1980	to	May	2016)	to	determine	the	dissociation	reagents,	 concentrations,	 and	 time	 outlined	 in	literature.	All	trials	outlining	the	methods	used	to	dissociate	native	rat,	mouse,	hamster,	or	human	islets	were	included.		Each	of	 the	3	native	post-mortem	human	islet	samples	(1	 female	and	2	male;	ages	41,	56,	and	 75;	 all	 negative	 for	 HIV,	 HCV,	 HBV	 testing;	isolated	and	supplied	by	Clinical	Islet	Laboratory	at	University	of	Alberta)	were	centrifuged	at	120	x	 g	 for	 1	minute	 in	 50	mL	 centrifuge	 tubes	 and	after	 removing	 the	 supernatant,	 resuspended	 in	CMRL-1066	 media	 (containing	 amino	 acids,	vitamins,	 and	 other	 components).	 The	 samples	were	 further	 divided	 into	 several	 tubes	 and	centrifuged	at	120	x	g	for	1	minute.	Two	thousand	islet	 equivalents	 (islets	 with	 a	 diameter	 of	 150	μm)	per	1	mL	of	dissociation	reagents	(Accutase,	Accumax,	 TrypLE	 Express,	 0.05%	 Trypsin	 in	phosphate-buffered	saline	(PBS),	0.05%	Trypsin	with	0.02%	Versene	(EDTA)	in	PBS,	and	Dispase	in	PBS	ranging	from	2	–	5	U/mL)	were	added	with	0.0015%	DNase	into	each	of	the	tubes.	Accumax	contains	the	same	proteolytic	and	collagenolytic	enzymes	 as	 Accutase,	 but	 is	 three	 times	 more	concentrated.	 Trypsin	 is	 a	 pancreatic	 serine	protease,	while	TrypLE	Express	is	a	recombinant	enzyme.	Dispase	contains	neutral	protease	 from	
Bacillus	polymyxa.	During	the	dissociation	period,	tubes	with	Accutase	or	Accumax	were	left	at	room	temperature	due	to	their	sensitivity	to	heat	while	the	rest	of	the	tubes	were	put	into	a	37	°C	shaking	water	bath	to	speed	up	the	dissociation	process.	Subsequently,	 the	 cells	 were	 mechanically	dissociated	 into	 single-cell	 suspensions	 by	trituration.	After	11-15	minutes,	 the	 tubes	were	topped	up	with	CMRL	media	to	5	mL	in	order	to	stop	the	dissociation	process.		The	 cells	were	 centrifuged	 at	 280	 x	 g	 for	 1	minute	 and	 resuspended	 in	 5	 mL	 of	 CMRL.	Samples	 were	 collected	 from	 the	 tubes	 for	 cell	counting	(pre-filtering	viability/	cell	counts),	and	
the	remaining	were	filtered	using	cell	strainers	to	obtain	uniform	cell	 suspensions.	After	 filtration,	cell	counting	samples	were	obtained	again	(post-filtering	 viability/	 cell	 counts).	 Samples	 were	analyzed	using	Trypan	Blue	and	PicoGreen	DNA	assay	to	quantify	cell	loss	during	islet	dispersion	and	 filtration.	 The	 cell	 suspensions	were	 added	into	24-well	AggreWell	plates	with	CMRL	in	them	and	centrifuged	at	200	x	g	for	5	minutes	to	form	smaller,	uniform	pseudo-islets.	The	pseudo-islets	were	 cultured	 in	 microwells	 in	 a	 cell	 culture	incubator	(37	°C,	5%	carbon	dioxide)	up	to	5	days	(5	 day	 cell	 viability/	 cell	 counts).	 During	 the	culture	 period,	 samples	 for	 cell	 counting	 were	collected	 and	 assessed	 using	 PicoGreen	 DNA	assay	while	the	metabolic	activity	of	pseudo-islets	was	assessed	using	Alamar	Blue	assay.	Statistical	analysis	were	performed	with	one-way	ANOVA.				
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